Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are two common gut conditions that affect millions of people worldwide, IBS affecting 10-15% of the global population, whereas IBD impacts about 1.3% of the population. While they share some symptoms, they are distinct in their causes and characteristics.
Inflammatory Bowel Disease (IBD), encompassing Crohn's disease and ulcerative colitis, wreaks havoc on the millions of lives affect. IBD’s causes are multidimensional, with a complex interplay of genetics, immune response, diet and environmental factors that ignite the flames of inflammation in IBD patients.
This webinar delves into the considerable depths of these triggers, unearthing their influence on disease activity, and paving the way for optimal treatment strategies. We will unmask the culprits of microbiome metabolomic mapping, genetic susceptibility, immune biomarkers, and dive into external factors such as diet, stress, and infections that can tip the scales towards IBD.
In this webinar you will learn:
